Warthin's tumor surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
[[Surgery]] is the mainstay of treatment for Warthin's tumor.
[[Surgery]] is the mainstay of treatment for Warthin's tumor.
==Surgery==
==Surgery==
* Most of these tumors are treated with surgical removal. Recurrence is rare, occurring in 6 - 12% of cases.  Warthin's tumor is highly unlikely to become [[malignant]].
* Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases.  Warthin's tumor is highly unlikely to become [[malignant]].
* [[Surgery]] should be followed by careful observation to watch for changes in the tumor over time.<ref name="pmid12593546">{{cite journal| author=Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL| title=Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review. | journal=J Otolaryngol | year= 2002 | volume= 31 | issue= 6 | pages= 351-4 | pmid=12593546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12593546  }} </ref>. Frey syndrome has been successfully treated with injections of botulinum toxin A<ref>Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq  Accessed on January 4, 2016</ref>  
* [[Surgery]] should be followed by careful observation to watch for changes in the tumor over time.<ref name="pmid12593546">{{cite journal| author=Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL| title=Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review. | journal=J Otolaryngol | year= 2002 | volume= 31 | issue= 6 | pages= 351-4 | pmid=12593546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12593546  }} </ref>. Frey syndrome has been successfully treated with injections of botulinum toxin A<ref>Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq  Accessed on January 4, 2016</ref>  
==References==
==References==

Revision as of 21:29, 12 January 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Warthin's tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Warthin's tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Biopsy

Treatment

Surgery

Cost-Effectiveness of Therapy

Case Studies

Case #1

Warthin's tumor surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Warthin's tumor surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Warthin's tumor surgery

CDC on Warthin's tumor surgery

Warthin's tumor surgery in the news

Blogs on Warthin's tumor surgery

Directions to Hospitals Treating Warthin's tumor

Risk calculators and risk factors for Warthin's tumor surgery

Overview

Surgery is the mainstay of treatment for Warthin's tumor.

Surgery

  • Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases. Warthin's tumor is highly unlikely to become malignant.
  • Surgery should be followed by careful observation to watch for changes in the tumor over time.[1]. Frey syndrome has been successfully treated with injections of botulinum toxin A[2]

References

  1. Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL (2002). "Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review". J Otolaryngol. 31 (6): 351–4. PMID 12593546.
  2. Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq Accessed on January 4, 2016

Template:WH Template:WS